Long-term survival in AIDS-related primary central nervous system lymphoma

Conclusion.
Long-term disease-free survival can be achieved in AR-PCNSL, even among those with histories of opportunistic infections, limited access to health care, and medical non-adherence. Given this, as well as the long-term toxicities of WBRT, we recommend that integration of cART plus first-line HD-MTX be considered for all patients with AR-PCNSL.

Source: Neuro-Oncology - December 26, 2016 Category: Cancer & Oncology Authors: Gupta, N. K., Nolan, A., Omuro, A., Reid, E. G., Wang, C.-C., Mannis, G., Jaglal, M., Chavez, J. C., Rubinstein, P. G., Griffin, A., Abrams, D. I., Hwang, J., Kaplan, L. D., Luce, J. A., Volberding, P., Treseler, P. A., Rubenstein, J. L. Tags: Clinical Investigations Source Type: research